These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1148 related articles for article (PubMed ID: 10811123)
1. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity. Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123 [TBL] [Abstract][Full Text] [Related]
2. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo. Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140 [TBL] [Abstract][Full Text] [Related]
3. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells. Okada H; Villa L; Attanucci J; Erff M; Fellows WK; Lotze MT; Pollack IF; Chambers WH Gene Ther; 2001 Aug; 8(15):1157-66. PubMed ID: 11509946 [TBL] [Abstract][Full Text] [Related]
4. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors. Iwadate Y; Yamaura A; Sato Y; Sakiyama S; Tagawa M Cancer Res; 2001 Dec; 61(24):8769-74. PubMed ID: 11751397 [TBL] [Abstract][Full Text] [Related]
5. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production. Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699 [TBL] [Abstract][Full Text] [Related]
6. Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine. Okada H; Giezeman-Smits KM; Tahara H; Attanucci J; Fellows WK; Lotze MT; Chambers WH; Bozik ME Gene Ther; 1999 Feb; 6(2):219-26. PubMed ID: 10435106 [TBL] [Abstract][Full Text] [Related]
7. NKR-P1+ cells localize selectively in Rat 9L gliosarcomas but have reduced cytolytic function. Chambers WH; Bozik ME; Brissette-Storkus SC; Basse P; Redgate E; Watkins S; Boggs SS Cancer Res; 1996 Aug; 56(15):3516-25. PubMed ID: 8758920 [TBL] [Abstract][Full Text] [Related]
8. Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors. Iwadate Y; Tagawa M; Namba H; Oga M; Kawamura K; Tasaki K; Sakiyama S; Yamaura A Cancer Gene Ther; 2000 Sep; 7(9):1263-9. PubMed ID: 11023199 [TBL] [Abstract][Full Text] [Related]
9. Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination. Liau LM; Jensen ER; Kremen TJ; Odesa SK; Sykes SN; Soung MC; Miller JF; Bronstein JM Cancer Res; 2002 Apr; 62(8):2287-93. PubMed ID: 11956085 [TBL] [Abstract][Full Text] [Related]
10. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
11. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes. Martinotti A; Stoppacciaro A; Vagliani M; Melani C; Spreafico F; Wysocka M; Parmiani G; Trinchieri G; Colombo MP Eur J Immunol; 1995 Jan; 25(1):137-46. PubMed ID: 7843224 [TBL] [Abstract][Full Text] [Related]
12. Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas. Yang T; Witham TF; Villa L; Erff M; Attanucci J; Watkins S; Kondziolka D; Okada H; Pollack IF; Chambers WH Cancer Res; 2002 May; 62(9):2583-91. PubMed ID: 11980653 [TBL] [Abstract][Full Text] [Related]
13. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor. Björkdahl O; Dohlsten M; Sjögren HO Cancer Gene Ther; 2000 Oct; 7(10):1365-74. PubMed ID: 11059695 [TBL] [Abstract][Full Text] [Related]
14. Granulocyte macrophage-colony stimulating factor gene transfer to induce a protective anti-tumoral immune response against the 9L rat gliosarcoma model. Lefranc F; Cool V; Velu T; Brotchi J; De Witte O Int J Oncol; 2002 May; 20(5):1077-85. PubMed ID: 11956607 [TBL] [Abstract][Full Text] [Related]
15. Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene. Benedetti S; Bruzzone MG; Pollo B; DiMeco F; Magrassi L; Pirola B; Cirenei N; Colombo MP; Finocchiaro G Cancer Res; 1999 Feb; 59(3):645-52. PubMed ID: 9973213 [TBL] [Abstract][Full Text] [Related]
16. [The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination]. Luo F; Mao YQ; Kan B; He QM; Jiang Y; Peng F; Yang L; Tian L Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):757-60. PubMed ID: 15573746 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-12-mediated induction of systemic immunity in the periphery and recruitment of activated T cells into the brain produce limited antitumor effects compared with interleukin-2. Iwadate Y; Namba H; Sakiyama S; Yamaura A; Tagawa M Int J Mol Med; 2002 Dec; 10(6):741-7. PubMed ID: 12430001 [TBL] [Abstract][Full Text] [Related]
18. Elicitation of a systemic and protective anti-melanoma immune response by an IL-2-based vaccine. Assessment of critical cellular and molecular parameters. Zatloukal K; Schneeberger A; Berger M; Schmidt W; Koszik F; Kutil R; Cotten M; Wagner E; Buschle M; Maass G J Immunol; 1995 Apr; 154(7):3406-19. PubMed ID: 7897222 [TBL] [Abstract][Full Text] [Related]
19. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077 [TBL] [Abstract][Full Text] [Related]
20. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity. Yang X; Chu Y; Wang Y; Zhang R; Xiong S J Leukoc Biol; 2006 Dec; 80(6):1434-44. PubMed ID: 16980511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]